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Objective In previous studies, we have shown a three to four times
higher urban incidence of breast cancer and estrogen receptor-
positive breast cancers in the Gharbiah Province of Egypt. We
investigated the urban–rural incidence differences of gynaecologic
malignancies (uterine, ovarian and cervical cancers) to explore if
they show the same trend that we found for breast cancer.
Design Cancer registry-based incidence comparison.
Setting Gharbiah population-based cancer registry (GPCR), Tanta,
Egypt.
Sample All patients with uterine, ovarian and cervical cancer in
GPCR from 1999 to 2002.
Methods We calculated uterine, ovarian and cervical cancer
incidence from 1999 to 2002. For each of the three cancers, we
calculated the overall and age-specific rates for the province as a
whole, and by urban–rural status, as well as for the eight districts
of the province.
Results Incidence of all three cancer sites was higher in urban
than in rural areas. Uterine cancer showed the highest urban–rural
incidence rate ratio (IRR = 6.07, 95% CI = 4.17, 8.85). Uterine
cancer also showed the highest urban incidence in the oldest age
group (70+ age category, IRR = 14.39, 95% CI = 4.24, 48.87) and
in developed districts (Tanta, IRR = 4.14, 95% CI = 0.41, 42.04).
Incidence rates by groups of cancer sites showed an increasing
gradient of urban incidence for cancers related to hormonal
aetiology, mainly of the breast and uterus (IRR = 4.96, 95%
CI = 2.86, 8.61).
Conclusions The higher urban incidence of uterine cancer, coupled
with our previous findings of higher incidence of breast cancer and
estrogen receptor positive breast cancer in urban areas in this region,
may be suggestive of possible higher exposure to environmental
estrogenic compounds, such as xenoestrogens, in urban areas.
Keywords Egypt, gynaecologic cancers, urban–rural,
xenoestrogens.
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Introduction
Malignancies specific to female organs, such as those of
breast, uterus, and ovary, tend to have a hormone-related
aetiology.1–3 Reproductive risk factors that increase the
exposure of women to higher levels of endogenous estrogens
seemingly lead to an increased risk of such cancers.1–3 The
malignancies of these three organs also have higher incidence
rates in more affluent or developed countries compared with
the developing world.4 However, among these three organ
sites, breast cancer is the most common cancer with the
highest incidence in most populations across the world.4,5
This difference in incidence between various organ sites may
be the result of differences in tissue structure of the organs
and their anatomical site, and/or physiological function,
which translates into differences in exposure.
Cervical cancer is also a malignancy that is specific to
women, but has a risk profile and epidemiology quite
unlike that of cancers of the breast, ovary, or uterus. Cervi-
cal cancer has mainly an infectious aetiology, and the
human papillomavirus (HPV) is found to be implicated in
most cases of cervical cancer.6 As is true for most infec-
tious diseases, cervical cancer has a higher incidence in
developing and more tropical countries.
Within developing countries, urban areas tend to be
more affluent and developed compared with rural areas. This




difference in development and industrialisation translates
into differences in exposure to certain man-made chemicals
called xenoestrogens that have been shown to act like natural
hormones within the body, and have been implicated in
numerous in vitro, animal, and human studies to increase
the risk of breast cancer.7 Numerous studies across the world
have shown that xenoestrogen presence and exposure is
higher in urban areas of the world.8–14 Over the past several
years we have explored the differences between developed
and developing populations, with a special focus on Egypt,
where distinct differences between urban and rural areas
exist15,16 and may provide a unique setting for investigating
the association between development and urbanisation, and
differences in cancer incidence and distribution.
We have already published our hypotheses regarding the
probable association between xenoestrogens and breast can-
cer,17 and in our previous studies in Gharbiah, Egypt, we
also found a three to four times higher incidence of breast
cancer and estrogen receptor positive (ER+) breast tumours
in urban areas than in rural areas.18 Because of the hor-
monal aetiology of breast cancer and the likelihood that
populations in urban areas might be exposed to xenoesto-
genic compounds, as shown in urban areas of other coun-
tries,8–14 we hypothesised that the incidence of other
gynaecological malignancies such as those of the uterus and
ovary must be higher in urban populations. At the same
time, higher xenoestrogen exposure must not have any effect
on creating urban–rural differences for cervical cancer,
which does not have a hormonal aetiology. Thus, we exam-
ined the hypothesis that the incidence of uterine and ovarian
cancer is higher in urban areas as compared with rural areas,
whereas the incidence of cervical cancer is not significantly
different between urban and rural areas in Gharbiah, Egypt.
For these purposes we analysed the data from the popula-
tion-based Gharbiah Cancer Registry for the 4-year period
of 1999–2002 to assess differences in urban–rural incidence
of uterine, ovarian and cervical cancers.
Methods
The methods of this study are similar to the methods pub-
lished previously.18 Here we have provided the methods
specific to this study in brief.
Study population
The study population consisted of all women diagnosed with
uterine, ovarian and cervical cancer from 1999 to 2002, a
total period of four years, in the Gharbiah population-based
cancer registry (GPCR), Tanta, Egypt. The registry number,
age at diagnosis, address, address code, smoking status, occu-
pation, basis of diagnosis, tumour grade, stage, morphology,
medical record number and place of reference of each woman
were abstracted from routinely collected registry data.
Gharbiah population-based cancer registry
The Gharbiah population-based cancer registry was
founded in 1998 as a part of the Middle East Cancer Con-
sortium (MECC), and is located in Tanta, the capital of
Gharbiah Province.19 This is an active registry and it col-
lects cases from a number of sources in the governorate to
determine cancer incidence. Most of the cancer cases for
this study came from Tanta Cancer Center (40–50%) and
Gharbiah Cancer Society (20–25%). The remaining cases
came from pathology laboratories (10%), Mansoura Radio-
therapy Hospital (3–4%), insurance hospitals (4–5%),
National Cancer Institute (NCI), Cairo (2–3%) and mortal-
ity records (4–5%). Most of the cases were diagnosed by
pathological confirmation.20 The WHO ICD-9 coding is
used to determine the types of cancer. Cases were regis-
tered with Surveillance Epidemiology and End Results
(SEER) staging information from 1999–2002, although all
available records for patients from 1999 to 2002 was
retrieved, and previous SEER staging was replaced by
American Joint Committee on Cancer (AJCC) staging.
Gharbiah Province
Gharbiah Province is an administrative region located
90 km north of Cairo in the Nile Delta Region. It has eight
districts, with Tanta being the capital of Tanta district as
well as of the entire governorate. Gharbiah has a popula-
tion of more than 4 million people, and 49% of them are
women. Approximately 30% of the population resides in
urban areas and almost 47% of the female population is
below the age of 20, according to the 2006 Central Agency
for Public Mobilization and Statistics (CAPMAS) census.21
Most of the residents residing in rural areas are part of an
agricultural economy, but most people living in cities par-
ticipate in industrial occupations, with most of the indus-
tries located in the two largest districts of Tanta and
El Mehalla.
Census data
Census data for the female population in Gharbiah was
obtained from the 1996 and 2006 CAPMAS census,21 and a
constant growth of the population was assumed in order to
project populations for the years in between using a linear
regression model. The linear growth rates of eight districts
were applied to the urban and rural populations within
those districts to determine the urban and rural popula-
tions from 1999 to 2002. The census data consisted of 16
age categories at 5-year intervals. Six age categories were
created from these by collapsing the age categories below
29 years, and by collapsing the age categories into 10-year
intervals after that. These population figures formed the
denominators to calculate the overall, age-specific, district-
specific and urban–rural incidence rates for uterine, ovarian
and cervical cancer in women.
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Urban–rural classification
The urban–rural classification followed the CAPMAS cod-
ing of urban and rural areas. Urban areas consisted of all
the capital cities of the eight districts of the governorate,
whereas the remaining areas in the governorate were con-
sidered to be rural. Each case in the registry is assigned a
residence code based on their residential address that fol-
lows the CAPMAS coding. This code was used to classify
patients as being either urban or rural.
Statistical analyses
Descriptive statistics and rate analyses were completed
using SAS 9.1.3 (SAS Institute, Cary, NC, USA). Univariate
analyses were used to develop a descriptive profile using
demographic and geographical indicators. Yearly raw and
age-adjusted incidence rates for uterine, ovarian and cervi-
cal cancer were calculated for Gharbiah governorate, each
of the eight districts, and urban and rural areas for the
governorate and each district. Age-specific rates, overall
and urban–rural, were calculated for each of six age catego-
ries. Raw incidence rates were calculated by taking the
number of cases per year (1999–2002) divided by the per-
son-year estimates for 1999–2002. Direct age-adjusted inci-
dence rates were calculated by direct age-standardization
for each district, and their urban and rural areas, using the
world population as the standard.4 We also compared
world age-standardised overall and urban–rural incidence
rates with SEER incidence rates from the USA. Incidence
rate ratios (IRRs) and P-values for the trends were calcu-
lated using negative binomial regression by the GENMOD
procedure in SAS. Age, histology and stage at diagnosis
could have been potential confounding factors. However,
histology was uniform in distribution across urban–rural
strata, and stage at diagnosis did not affect IRRs by more
than 10%. Therefore, we have reported age-standardised
IRRs and 95% confidence intervals (CIs).
As additional analyses following our initial results, we also
compared urban–rural incidence of female leukaemia (a can-
cer with mostly genetic and some environmental aetiology,
which will thus be most likely to have the least differences
between urban and rural populations), all female cancers
except breast and uterine cancer (two cancers with maximal
links to hormonal risk factors in addition to other factors),
all female cancers (including breast and uterine cancer), and
hormonal cancers (breast and uterus).
Results
The number of cases was highest for ovarian cancer, fol-
lowed by uterine and cervical cancer, respectively (Table 1).
The numbers of cases of ovarian and uterine cancers were
fairly constant across the years 1999–2002. There was some
Table 1. Characteristics of women with uterine, ovarian and cervical cancer by urban–rural status in Gharbiah, Egypt, from 1999 to 2002
Variable Descriptive Category Uterus Ovary Cervix
Urban No. (%) Rural No. (%) Urban No. (%) Rural No. (%) Urban No. (%) Rural No. (%)
Total cases 101 (73.19) 37 (26.81) 148 (53.62) 128 (46.38) 60 (58.25) 43 (41.75)
Year of diagnosis 1999 17 (62.96) 10 (37.04) 29 (46.03) 34 (53.97) 15 (53.57) 13 (46.43)
2000 27 (72.97) 10 (27.03) 34 (55.74) 27 (44.26) 25 (65.79) 13 (34.21)
2001 24 (68.57) 9 (25.71) 38 (50.67) 37 (49.33) 9 (56.25) 7 (43.75)
2002 33 (80.49) 8 (19.51) 47 (61.04) 30 (38.96) 11 (52.38) 10 (47.62)
Age 0–29 1 (100) 0 16 (45.71) 19 (54.29) 1 (100) 0
30–39 4 (100) 0 26 (63.41) 15 (48.39) 5 (62.50) 3 (37.50)
40–49 16 (66.67) 8 (33.33) 33 (55.00) 27 (45.00) 11 (50.00) 11 (50.00)
50–59 30 (68.18) 14 (31.82) 34 (47.22) 38 (52.78) 18 (60.00) 12 (40.00)
60–69 32 (72.73) 12 (27.27) 26 (55.32) 21 (44.68) 20 (64.52) 11 (35.48)
70+ 18 (85.71) 3 (14.29) 13 (61.91) 8 (38.10) 5 (45.46) 6 (54.54)
District Tanta 51 (80.95) 12 (19.05) 67 (62.62) 40 (37.38) 30 (69.77) 13 (30.23)
El-Mehalla 25 (71.43) 10 (28.57) 39 (59.09) 27 (40.91) 19 (73.08) 7 (26.92)
Kafr El-Zayat 6 (66.67) 3 (33.33) 10 (52.63) 9 (47.37) 3 (50) 3 (50)
Zefta 8 (66.67) 4 (33.33) 10 (58.82) 7 (41.18) 1 (25) 3 (75)
Samanoud 2 (100) 0 5 (41.67) 7 (58.33) 2 (28.57) 5 (71.43)
El Santa 3 (60) 2 (40) 7 (25.93) 20 (74.07) 2 (28.57) 5 (71.43)
Kotoor 3 (37.5) 5 (62.5) 3 (30) 7 (70) 2 (25) 6 (75)
Basyoon 3 (75) 1 (25) 7 (38.89) 11 (61.11) 1 (100) 0
Basis of diagnosis Microscopic 90 (72) 35 (28) 132 (54.1) 112 (45.9) 59 (58.42) 42 (41.58)
Non-microscopic 1 (100) 0 7 (30.44) 16 (69.56) 1 (100) 0
Death certificate 10 (83.33) 2 (16.67) 9 (100) 0 0 1 (100)
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variation seen in the number of cervical cancer cases, with
only 13 cases seen in 2001, but with 38 cases registered in
2000. For most organ sites and for most ages, the number
of urban cases was higher, except for ovarian cancer (1999
and 0–29 age category). Among districts, most cases for all
cancer sites came from Tanta, the largest district. Most of
the cases were diagnosed microscopically.
Crude incidence per 100 000 women for all three cancers
was low, with cervical cancer having the lowest incidence
(uterus, 1.91; ovary, 3.83; cervix, 1.43) (Table 2). However,
the urban incidence of all three cancers was higher than
the rural incidence – the highest difference being seen for
uterine cancer (IRR = 6.07, 95% CI = 4.17, 8.85). Age-
standardised rates for all cancer sites were much lower than
US SEER (white) rates for all three cancer sites.
The overall age-specific incidence of the three cancers
shows that these are diseases of old age, and that the inci-
dence increases with increasing age (Table 3). A peak in
incidence was seen for the age group of 50–59 years for
ovarian and 60–69 years for uterine and cervical cancers. A
comparison of age-specific urban and rural incidence
showed some interesting features for all three cancers. For
all cancer sites, urban incidence was higher than rural inci-
dence from an early age, and urban incidence kept increas-
ing with age, with the highest incidence seen in the 70+
age category for urban areas, except for cervical cancer.
Rural incidence, however, peaked at 60–69 years and then
declined. The differences in incidence between urban and
rural areas were much wider for uterine cancer in most age
groups compared with the other two cancer sites, with the
highest difference seen in the 70+ age group (IRR = 14.39,
95% CI = 4.24, 48.87).
Among the districts, Tanta had the highest incidence for
all three cancer sites (Table 4). For ovarian cancer the inci-
dence in Tanta was slightly higher compared with Basyoon
(IRR = 1.56, 95% CI = 0.45, 5.49), whereas the incidence
was almost similar in the other districts. For uterine (Fig-
ure 1) and cervical cancers, the incidence in Tanta was
much higher compared with Basyoon (Uterus, IRR = 4.14,
95% CI = 0.41, 42.04; Cervix, IRR = 11.31, 95% CI = 0.15,
867.4) (Table 4). However, because of the very low number
of cases these estimates had large standard errors, and inci-
dence rates may not be too different between the districts.
We also looked at female leukaemia and other female
cancers in the groups to observe any gradients in terms of
urban–rural differences in incidence in Gharbiah (Table 5).
We found that leukaemia had the lowest urban–rural
differences (overall IRR = 2.24, 95% CI = 0.55, 9.18),
Table 2. Overall, urban and rural incidence, crude and age-standardised to the world population, and urban–rural incidence rate ratios for
uterine, ovarian and cervical cancer in Gharbiah, Egypt
Organs Incidence (per 100 000 women) and incidence rate ratios
Crude* Crude urban Crude rural IRR (95% CI) ASW ASW urban ASW rural ASW IRR ASW US SEER (white)
Uterus 1.91 4.52 0.74 6.07 (4.17, 8.85) 2.94 6.63 1.17 5.68 18.4
Ovary 3.83 6.62 2.57 2.57 (2.03, 3.26) 5.02 8.15 3.50 2.33 13.2
Cervix 1.43 2.68 0.86 3.11 (2.10, 4.59) 2.09 3.68 1.31 2.80 6.8
ASW, age-standardised to the world population; IRR, incidence rate ratio.
*Crude incidence rate.
Table 3. Overall and urban–rural age-specific incidence rates*, and urban-rural incidence rate ratios of uterine, ovarian and cervical cancers in
Gharbiah, Egypt
Age groups Uterus Ovary Cervix
Overall Urban Rural IRR (95% CI) Overall Urban Rural IRR (95% CI) Overall Urban Rural IRR (95% CI)
0–29 0.02 0.07 0.00 – 0.77 1.19 0.59 2.02 (1.04, 3.93) 0.02 0.07 0.00 –
30–39 0.39 1.18 0.00 – 4.03 7.66 2.21 3.47 (1.84, 6.55) 0.79 1.47 0.44 3.33 (0.80, 13.95)
40–49 3.25 5.95 1.70 3.50 (1.50, 8.17) 8.12 12.28 5.75 2.14 (1.29, 3.55) 2.98 4.09 2.34 1.75 (0.76, 4.03)
50–59 10.12 20.17 4.89 4.12 (2.19, 7.78) 16.55 22.86 13.28 1.72 (1.08, 2.73) 6.90 12.10 4.19 2.89 (1.39, 5.99)
60–69 14.53 32.60 5.84 5.59 (2.88, 10.85) 15.52 26.49 10.21 2.59 (1.46, 4.61) 10.24 20.38 5.35 3.81 (1.83, 7.95)
70+ 14.01 40.81 2.84 14.39 (4.24, 48.87) 14.01 29.47 7.56 3.90 (1.62, 9.41) 7.34 11.34 5.67 2.00 (0.61, 6.55)
IRR, incidence rate ratio.
*All incidence rates are per 100 000 women.
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Table 4. Incidence rates* and incidence rate ratios of uterine, ovarian and cervical cancer by districts of Gharbiah, Egypt
Districts Uterus Ovary Cervix
Incidence IRR (95% CI) Incidence IRR (95% CI) Incidence IRR (95% CI)
Tanta 3.68 4.14 (0.41, 42.04) 6.25 1.56 (0.45, 5.49) 2.51 11.31 (0.15, 867.37)
El-Mehalla 1.89 2.12 (0.17, 26.46) 3.56 0.89 (0.21, 3.71) 1.40 6.31 (0.07, 555.26)
Kafr El-Zayat 1.30 1.47 (0.10, 21.78) 2.75 0.69 (0.15, 3.20) 0.87 3.92 (0.04, 414.13)
Zefta 1.55 1.75 (0.13, 23.73) 2.20 0.55 (0.11, 2.85) 0.52 2.33 (0.02, 336.7)
Samanoud 0.37 0.42 (0.01, 19.27) 2.23 0.56 (0.11, 2.87) 1.30 5.85 (0.06, 527.23)
El Santa 0.76 0.85 (0.04, 18.29) 4.09 1.02 (0.26, 4.06) 1.06 4.77 (0.05, 462.93)
Kotoor 1.51 1.70 (0.12, 23.36) 1.88 0.47 (0.08, 2.67) 1.51 6.79 (0.08, 584.62)
Basyoon 0.89 1.00 4.00 1.00 0.22 1.00
IRR, incidence rate ratio.
*All incidence rates are per 100 000 women.
Figure 1. Location of the eight districts of Gharbiah in the Nile Delta Region of Egypt, and the incidence of uterine cancer (per 100 000 women) by
district.
Table 5. Incidence rates* and incidence rate ratios of female cancers by groups in Gharbiah, Egypt
Sites 1999 2000 2001 2002 Overall
Urban Rural IRR Urban Rural IRR Urban Rural IRR Urban Rural IRR Urban Rural IRR (95% CI)
Female leukaemia 6.94 3.12 2.22 5.04 2.67 1.89 6.77 2.55 2.65 6.30 2.83 2.23 6.26 2.79 2.24 (0.55, 9.18)
All female cancers except
breast and uterus
96.98 34.44 2.82 96.67 33.53 2.88 96.91 36.25 2.67 103.71 35.91 2.89 98.61 35.05 2.81 (1.91, 4.14)
All female cancer sites 175.70 48.83 3.60 170.48 47.54 3.59 171.03 53.25 3.21 185.91 51.24 3.63 175.84 50.24 3.50 (2.56, 4.79)
Breast and uterus 75.25 14.39 5.23 72.73 14.09 5.16 71.62 16.61 4.31 81.15 15.56 5.22 75.22 15.17 4.96 (2.86, 8.61)
IRR, incidence rate ratio.
*All incidence rates are per 100 000 women.
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followed by all female cancers except those with the most
pronounced hormonal aetiology (breast and uterus) (over-
all IRR = 2.81, 95% CI = 1.91, 4.14). Finally, when we
included the cancer sites with hormonal aetiology, the
urban–rural incidence difference increased further (overall
IRR = 3.50, 95% CI = 2.56, 4.79). Looking at only hor-
monal cancer sites (breast and uterus), the urban–rural
incidence was much higher than any other cancer group
(overall IRR = 4.96, 95% CI = 2.86, 8.61).
Discussion
This study showed a higher incidence of uterine, ovarian and
cervical cancers in urban areas compared with rural areas in
the Gharbiah Province of Egypt. Furthermore, the most
striking finding was the almost six times higher incidence of
uterine cancer in urban areas than in rural areas of Gharbiah.
We also found a gradient of increasing urban–rural differ-
ence for all female cancers. Cancers such as leukaemia with
mainly genetic and some environmental risks (which will
likely lead to minimal differences between urban and rural
populations) had the lowest IRR, followed by the urban–
rural IRR seen for female cancers excepting cancers with
hormonal malignancies. On the inclusion of cancers with
hormonal malignancies in the group analyses, the IRR
increased by almost 70%. This urban–rural difference
increased further by 146% when we looked at only hormonal
cancers. In our previous studies we have found a three or
four times higher incidence of breast cancer and ER+ breast
cancer in urban areas of the Gharbiah Province.18 These
urban–rural differences seen for breast cancer, in addition to
a six times higher incidence of uterine cancer in urban areas,
clearly show that women in urban areas experience a much
higher exposure to hormonal risk factors of cancers.
In preparation for fertilisation, the uterus undergoes
cyclical changes every month mainly under the influence of
estrogen. Thus, the endometrium, which is rich in estrogen
receptors, shows the highest proliferation rate during the
first 18 days of the menstrual cycle.22 The ‘unopposed
estrogens’ hypothesis (long-term exposure to estrogens, not
counterbalanced by the presence of progesterone) is the
most widely accepted hypothesis on the aetiology of endo-
metrial cancer.22 Given the fact that urban and rural
women in Egypt are genetically similar, and that most of
the risk factors of uterine cancer are environmental, it can
be inferred that urban women in Egypt have a higher expo-
sure to environmental estrogens compared with rural
women. It is clear from large surveys such as the Egyptian
Demographic and Health Survey (EDHS) that in Egypt dif-
ferences in reproductive factors are not substantial between
urban and rural women.23 For example, the total fertility
rate (TFR) for urban women and rural women is 2.7 and
3.0, respectively, in Lower Egypt (the area of Egypt in
which Gharbiah is located).23 Also, as oral contraceptive
use (which is protective for uterine cancer, and is most
likely to be used by urban women) is quite low among
Egyptian women,23 there are probably other environmental
estrogenic factors that are leading to the higher urban inci-
dence of uterine cancer.
The presence of and exposure to xenoestrogens are much
higher in urban areas than in rural areas, a fact that has
been seen in many populations across the world.8–14
Because of the high rate of development of the urban cen-
tres of Egypt, the exposure of women to xenoestrogens in
urban Egypt might be high. There have been very few stud-
ies looking at the effect of xenoestrogens on uterine cancer
in humans. However, animal studies show clearly that
xenoestrogens are quite capable of causing uncontrolled
uterine proliferation, usually through the same pathways by
which endogenous estrogens act.24,25 There are more stud-
ies related to the link between breast cancer and xenoestro-
gens, and we have already hypothesised that the higher
urban incidence of breast cancer is possibly a result of a
higher exposure to xenoestrogens.17
Obesity is the other leading risk factor of uterine cancer
worldwide, and has been known to explain 40% of endo-
metrial cancer incidence.26 However, the differences
between urban and rural women in terms of obesity are
minimal, with urban and rural women having a mean body
mass index (BMI) of 31.2 and 30.4, respectively, in Lower
Egypt, according to EDHS.23 Also, the percentage of obese
urban and rural women (as defined by a BMI ‡ 30) in
Lower Egypt was 56.4 and 50.6%, respectively.23 Thus, dif-
ferences in BMI cannot possibly explain the large urban–
rural differences in uterine cancer incidence. It is also likely
that uterine bleeding, the only way in which uterine cancer
is detected, is much more easily detectable in urban areas.
However, primary healthcare coverage in rural Egypt is
100%,27 and the remotest rural area in Gharbiah is not
more than 50 km away from the capital city of the prov-
ince. Thus, access to health care in Gharbiah is not too dif-
ferent between urban and rural areas. Also, the coverage of
the Gharbiah registry is quite high, and given the multiple
quality checks in the registry it is unlikely that many rural
cases are missed.
Nevertheless, we saw around a two times higher incidence
of ovarian cancer and leukaemia in urban areas, and a
almost three times higher incidence of cervical cancer in
urban areas in Gharbiah. Apart from differences in the
urban–rural distribution of risk factors, it is likely that there
might still be slight differences in healthcare access and
behaviour between urban and rural areas responsible for the
higher urban incidence of female cancers. In terms of aetiol-
ogy, ovarian cancer is not really a hormonally related can-
cer, as it is not under direct stimulatory effects of estrogen.
Ovarian cancer development is more related to risk factors
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that lead to chronic inflammation, related to ‘incessant ovu-
lation’.28,29 Thus, the observation of a lack of any large
urban–rural differences with regards to ovarian cancer is
explainable. Cervical cancer on the other hand is a cancer
that is much more closely related to sexual behaviour than
other cancers.6 The detection of cervical cancer is also
related to women’s access to gynaecological clinics, and as
such a higher urban incidence is possible. However, cervical
cancer has a very low incidence in Egypt, and given the low
number of cases it is much more difficult to draw clear
inferences regarding this site in the context of our study.
Overall, in this study we found an approximately six
times higher incidence of uterine cancer in urban areas,
and, in addition, the evidence from our recent studies
showed an almost four times higher urban incidence of
breast cancer and ER+ breast cancer.18 Thus, it is likely
that women in urban areas have a higher exposure to envi-
ronmental hormonal risk factors, possibly xenoestrogens.
This is especially the case in light of there being no sub-
stantial differences between urban and rural women with
regards to known risk factors of uterine and breast cancer.
Xenoestrogens are a preventable cause of cancer, and more
research at the individual level is required to clearly enu-
merate a possible association between xenoestrogens with
uterine and breast cancers.
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